Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2004 | 04-2004 | 01-2004 | 10-2003 | 07-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -53,972 | -38,759 | -20,212 | N/A |
| Depreciation Amortization | N/A | 2,547 | 1,737 | 860 | N/A |
| Accounts payable and accrued liabilities | N/A | -3,084 | 425 | -2,465 | N/A |
| Other Working Capital | N/A | -4,064 | 1,305 | -1,951 | N/A |
| Other Operating Activity | 0 | 3,199 | -368 | 2,499 | 0 |
| Operating Cash Flow | $N/A | $-55,374 | $-35,660 | $-21,269 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 60,200 | -22,570 | -36,132 | N/A |
| PPE Investments | N/A | -1,291 | -941 | -796 | N/A |
| Purchase Sale Intangibles | N/A | -5 | -5 | -5 | N/A |
| Other Investing Activity | 0 | -5 | -5 | -5 | 0 |
| Investing Cash Flow | $N/A | $58,904 | $-23,516 | $-36,933 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 46,186 | 44,864 | 44,278 | N/A |
| Financing Cash Flow | $N/A | $46,186 | $44,864 | $44,278 | $N/A |
| Beginning Cash Position | N/A | 24,844 | 24,844 | 24,844 | N/A |
| End Cash Position | N/A | 74,560 | 10,532 | 10,920 | N/A |
| Net Cash Flow | $N/A | $49,716 | $-14,312 | $-13,924 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -55,374 | -35,660 | -21,269 | N/A |
| Capital Expenditure | N/A | -1,291 | -941 | -796 | N/A |
| Free Cash Flow | 0 | -56,665 | -36,601 | -22,065 | 0 |